Recent advances in neurobiology have yielded clues about the abnormal
physiology of epilepsy and a better understanding of the action of the
established anticonvulsants, which were discovered fortuitously or in
animal screening tests. Some newer antiepileptic drugs may represent
an important improvement over existing therapy, especially if they sho
w efficacy in patients with intractable seizures or fewer limiting neu
rological side effects. Many developmental agents are designed to inte
ract with a specific target and employ one of three strategies: enhanc
ement of central inhibition; diminution of central excitation; or modu
lation of ionic channels regulating neuronal excitability. This articl
e reviews the anticonvulsant compounds in development, with a focus on
those being investigated in man. Updated information is also provided
about the mechanisms of action of the antiepileptic drugs presently u
sed as first line therapy.